Completed PHASE4 INTERVENTIONAL NCT00015301

Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Methylphenidate Raclopride PET Test

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cocaine-Related Disorders Substance-Related Disorders

Updated 6 times since 2017 Last updated: Feb 23, 2017 Started: Dec 31, 2003 Primary completion: Jun 30, 2005 Completion: Aug 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cocaine-Related Disorders and Substance-Related Disorders, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Mar 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Mar 2017 [monthly]

Completed PHASE4

First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
New York MDRU

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States